FBT

First Trust NYSE Arca Biotechnology Index Fund
*Unless otherwise stated, data provided by FactSet.

FBT Fund Description

FBT tracks an equal-weighted index of US biotechnology stocks.

FBT Factset Analytics Insight

FBT provides exposure to biotech companies involved in the use of biological processes to develop products or provide services. The underlying index contains 30 names, an increase from 20 in October 2014. Without a specific sector classification scheme, the fund’s broad exposure could include access to pharmaceuticals and medical technology in addition to traditional biotech. Still, FBT’s equal weighting of about 30 stocks produces a relatively concentrated basket. The index is reconstituted and rebalanced quarterly.

FBT MSCI ESG Analytics Insight

First Trust NYSE Arca Biotechnology Index Fund has an MSCI ESG Fund Rating of A based on a score of 6.48 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. First Trust NYSE Arca Biotechnology Index Fund ranks in the 60th percentile within its peer group and in the 94th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

FBT MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 09/15/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
FBT -0.05% -3.02% 0.99% 8.15% 3.85% 11.02% 16.95%
FBT (NAV) 1.50% -0.34% 2.55% 9.00% 4.42% 11.15% 16.99%
NYSE Arca Biotechnology (TR) 1.54% -0.20% 2.97% 9.64% 5.00% 11.74% 17.58%
Thomson Reuters US Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

FBT Summary Data

First Trust
06/19/06
Open-Ended Fund
0.55%
$1.88B
$5.69M
0.10%

FBT Portfolio Data

$33.13B
-54.09
4.83
0.00%
N/A
30

FBT Index Data

NYSE Arca Biotechnology (TR)
Equal
Market Cap
Thomson Reuters US Biotechnology & Medical Research

FBT Portfolio Management

0.55%
-0.64%
-0.55%
-1.63%

FBT Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

FBT Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

FBT Factset Analytics Block Liquidity

As of 09/16/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of FBT. FBT is rated a 5 out of 5.

FBT Tradability

33,483
$5.69M
28,095
$4.85M
0.10%
$0.16
-0.02%
0.53% / -0.14%
None
97.00%
50,000
0.56
0.01%
0.57%
152
$172.36
5

FBT Sector/Industry Breakdown


FBT
Segment Benchmark
43.69%
46.79%
33.45%
42.17%
9.71%
--
3.46%
--
3.15%
0.23%
3.10%
5.72%

FBT Countries


FBT
Segment Benchmark
92.03%
100.00%
4.79%
--
3.17%
--

FBT Regions


FBT
Segment Benchmark
92.03%
100.00%
7.97%
--

FBT Economic Development


FBT
Segment Benchmark
100.00%
100.00%

FBT Performance Statistics

0.79
0.78
0.85
0.81
0.74%
Thomson Reuters US Biotechnology & Medical Research

FBT MSCI ESG Ratings

6.48 / 10
93.77
60.23
--
39.05%
25.46

FBT Benchmark Comparison Holdings

30
261
23
36.25%

FBT Benchmark Comparison Summary


FBT
Segment Benchmark
30
261
$33.13B
$43.30B
-54.09
-58.34
4.83
6.44
0.27%
0.39%
Medium
High

FBT Benchmark Comparison Market Cap Size


FBT
Segment Benchmark
57.95%
58.24%
35.90%
25.73%
6.15%
13.19%
0.00%
2.85%